CML levels followed a similar trend to the hydroimidazolones (Figure 6C), but were present at ∼80-fold lower concentrations, based on the assumption of equal glycation of the BSA-MGO and BSA-CML standards (0.020±0.001 μg/mL BSA-CML equivalents at 100 μM MGO). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.